Figure 3.
Outcomes according to treatment of patients with limited-stage NLPHL. PFS (A), OS (B), LDFS (C), and DDFS (D) for patients with stage I/II NLPHL treated with RT only (n = 36), CMT (n = 29), or systemic therapy (ST) only (n = 6).
Outcomes according to treatment of patients with limited-stage NLPHL. PFS (A), OS (B), LDFS (C), and DDFS (D) for patients with stage I/II NLPHL treated with RT only (n = 36), CMT (n = 29), or systemic therapy (ST) only (n = 6).